Clinical Trial Update: A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN [Phase 1]

View source ↗

Summary

A Phase 1 pharmacodynamics study of VK0214 in male subjects with adrenomyeloneuropathy (AMN) associated with X-linked adrenoleukodystrophy (X-ALD) has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenomyeloneuropathy
• X-linked Adrenoleukodystrophy

Drugs mentioned

• VK0214

Snippet

Sponsor: Viking Therapeutics, Inc. | Conditions: Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) | Phase 1 | Status: COMPLETED